Valuable experience from working on vaccines for Ebola and MERS made it possible to roll out a drug against the novel coronavirus a lot quicker than many expected, the head of the research center behind Sputnik V told RT.
The Russian Health Ministry announced on Saturday that production of the world’s first registered coronavirus vaccine has begun. It’s been named ‘Sputnik V’ after the famed space satellite, launched by Moscow in 1957.
As Russia rolls out its new coronavirus inoculation ahead of complete clinical tests, the western media has suddenly come full circle on vaccines. Russia, it seems, could cure cancer and the media would find a way to blame Putin.
The Russian vaccine comes as countries around the world are bracing for the possibility of a second wave of coronavirus infections. The initial wave has already infected over 20 million people and claimed the lives of over 736,000, decimating many countries’ economies in the process.
The requests for access to the Russian pharmaceutical development emerged after President Vladimir Putin announced that the first vaccine against the coronavirus had been officially registered in the country after passing trials and that production would soon commence.
The emergence of the first vaccine against the coronavirus infection has sparked interest across the globe, as the drug promises not only an end to COVID-19-related deaths, but also a path to restoring a country’s economy.
The deliveries of the inactivated whole-virion vaccine to the international market will be possible only after Russia fully meets its needs for preventive preparations against COVID-19, Center Head Aidar Ishmukhametov said.
“Imunitatea lor este bună, se formează anticorpi şi sunt protejaţi împotriva coronavirusului”, a afirmat Svetlana Voltchikhina, medicul terapeut care coordonează studiile, într-un video difuzat de Ministerul Apărării.